Navigation Links
St. Joseph's scientist receives grant for post-partum research
Date:7/26/2011

(Phoenix Arizona, July 25, 2011) -- The Bill and Melinda Gates Foundation has awarded Robert Garfield, PhD, a researcher at St. Joseph's Hospital and Medical Center in Phoenix, a $100,000 phase 1 grant to develop a device to prevent post-partum hemorrhage.

The grant was one of 88 awarded in round six of Grand Challenges Explorations, a Gates Foundation initiative to help lower the barriers for testing innovative ideas in global health. Phase II of the grant will amount to $1 million.

Dr. Garfield is the director of research in the Department of Obstetrics and Gynecology at St. Joseph's. His research includes postpartum hemorrhage and preterm labor, two of the biggest problems facing pregnant women. The studies are also receiving additional funding from St. Joseph's Research Foundation and the National Institute of Health.

"Post-partum hemorrhage is the major cause of mortality in pregnant women. Worldwide, every minute one woman dies from complications of pregnancy with post-partum hemorrhage contributing more than 30 percent to this high mortality," says Dr. Garfield. "These studies, which are supported by the grant, can lead to important new ways to control bleeding in women following deliver of their babies."

The Gates Foundation grant will specifically assist Dr. Garfield in developing a compact, battery-powered device to electrically stimulate uterine contraction and prevent profuse bleeding following childbirth. The instrument could be used by any individual to reduce life-threatening postpartum hemorrhage in hospitals and in remote areas where prompt action is necessary.

"Minor post-partum hemorrhage is usually well controlled in developed countries like the United States with excellent medical facilities, doctors and medications," says Dr. Garfield. "However, major post-partum hemorrhage is a huge problem in underdeveloped countries."


'/>"/>

Contact: Lynne Reaves
602-406-4734
St. Joseph's Hospital and Medical Center
Source:Eurekalert

Page: 1

Related biology news :

1. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
2. Scientist plans to test for blood pressure genes affected by age
3. Scientists identify novel inhibitor of human microRNA
4. Argonne scientists peer into heart of compound that may detect chemical, biological weapons
5. MU scientists go green with gold, distribute environmentally friendly nanoparticles
6. Scientists identify gene that may contribute to improved rice yield
7. Scientists discover why a mothers high-fat diet contributes to obesity in her children
8. MU scientists see how HIV matures into an infection
9. Earth scientists keep an eye on Texas
10. Thinking it through: Scientists call for policy to guide biofuels industry toward sustainability
11. Scientists identify a molecule that coordinates the movement of cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2015)...  VOXX International Corporation (Nasdaq: VOXX ) ... Definitive Agreement to purchase the assets, inclusive of ... EyeLock through an acquiring entity.  Upon consummation of ... in the acquiring entity. The closing of the ...  Expanding on its existing supply chain and distribution ...
(Date:8/18/2015)... , Aug. 17, 2015 Research ... addition of the "Global Biometric Authentication & ... - Estimation & Forecast, 2015-2020" report to ... authentication and identification systems market is expected to ... 2015 to 2020 and generate over $25 billion ...
(Date:8/12/2015)... Minn. , Aug. 12, 2015   MedNet ... supports the entire spectrum of clinical research, is proud ... , the company,s comprehensive SaaS-based eClinical technology platform, has ... during the first two quarters of 2015.   Q2 ... second largest quarters measured by contract value sold in ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2MedNet Solutions Experiences Explosive Corporate Growth 2
... An improved technique for culturing cells, developed at the ... new, fundamental insights into the behavior of neuronal cells. ... a basic technique for measuring how they respond to ... tasks. Neuronal cells, which make up the central nervous ...
... "dead zone" has formed off the Oregon Coast for the ... State University. , A fundamental new trend in atmospheric and ... begun, scientists say, and apparently is expanding its scope beyond ... effect of the low-oxygen zone is also being seen in ...
... into rheumatoid arthritis (RA), a chronic inflammatory joint disease. ... RA has been linked to an inherited susceptibility. ... siblings seems to be random. , In ... patients with RA, researchers at the University of Michigan ...
Cached Biology News:Neuronal cell cultures kept on the straight and narrow 2Marine 'dead zone' off Oregon is spreading 2Marine 'dead zone' off Oregon is spreading 3New genes implicated in rheumatoid arthritis 2
(Date:9/2/2015)... 2015 Research and Markets ( ... Jain PharmaBiotech,s new report "Nanobiotechnology Applications, ... An increasing use of ... is anticipated. Nanotechnology will be applied at ... formulations for optimal delivery to diagnostic applications ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. This ... as a characteristic that can be objectively measured ... or pathogenic processes as well as pharmacological responses ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
(Date:9/2/2015)... , September 2, 2015 BiondVax Pharmaceuticals ... the National Institute of Allergy and Infectious Diseases (NIAID), part ... Department of Health and Human Services (HHS), to launch a ... the United States in the 2015-16 timeframe. The ... candidate, Multimeric-001 (M-001), as a primer vaccine, which would be ...
Breaking Biology Technology:Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
... September 24 Shire Limited,(LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company,announces that at its Annual ... the,poll are as follows:, ... For* Against ... 301,376,910 4,696,170 25,441,808 Emmens ...
... 2nd Annual EBW Expo & Conference Held in Pittsburgh ... Attendees to Discuss New Technologies, ... America,s,premier showcase and educational forum for the growing business ... in clean, green,energy supply will take place in downtown ...
... Book signing to follow his presentation, WASHINGTON, ... the global marketplace, and the role of,financing are ... panel presentations will focus on the convergence of ... remote patient monitoring,technologies, critical issues to consider when ...
Cached Biology Technology:Results of the Annual General Meeting Held on September 24, 2008 2Results of the Annual General Meeting Held on September 24, 2008 3Former Speaker of the House Newt Gingrich Featured Wednesday 2
... CELlulose) was developed in the late 1960s ... of the earliest commercial pioneers of immunoassay ... range in 1987. Sac-Cel rapidly found favour ... own "in house" radioimmunoassays, and became a ...
Determin interaction of your protein with Echelons lipids...
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Biology Products: